238 | 0 | 34 |
下载次数 | 被引频次 | 阅读次数 |
目的 探讨miR-155-5p/沉默信息调节因子1(sirt1)信号通路对白色念珠菌诱导川崎病模型小鼠免疫功能的影响。方法 将C56BL/6小鼠分为对照组、川崎病组、拮抗剂对照组、miR-155-5p拮抗剂组、miR-155-5p拮抗剂+si-NC组、miR-155-5p拮抗剂+si-sirt1组,每组12只。除对照组外,其他组小鼠均通过腹腔注射白色念珠菌水溶物构建川崎病模型。建模成功后进行给药处理,1 d给药1次,持续7 d。qRT-PCR检测冠状动脉中miR-155-5p表达;Western blot检测冠状动脉中sirt1蛋白;HE染色检测冠状动脉的病理变化;检测小鼠胸腺指数和脾指数;流式细胞术检测外周血中辅助性T细胞17(Th17)/调节性T细胞(Treg);ELISA检测小鼠血清中白细胞介素(IL)-17、IL-10水平;验证sirt1与miR-155-5p靶向关系。结果 与对照组比较,川崎病组小鼠冠状动脉中有大量炎性细胞浸润,miR-155-5p表达、Th17比例、Th17/Treg比例、IL-17水平升高,sirt1蛋白表达、胸腺指数、脾指数、Treg比例、IL-10水平降低(均P<0.05);与川崎病组比较,miR-155-5p拮抗剂组小鼠冠状动脉中炎性细胞浸润现象有所缓解,miR-155-5p表达、Th17比例、Th17/Treg比例、IL-17水平降低,sirt1蛋白表达、胸腺指数、脾指数、Treg比例、IL-10水平升高(均P<0.05);si-sirt1减弱了抑制miR-155-5p对川崎病小鼠Th17/Treg平衡的促进作用以及对血管炎症的抑制作用,miR-155-5p靶向调控sirt1。结论 抑制miR-155-5p促进川崎病小鼠Th17/Treg平衡,抑制血管炎症的机制可能与上调sirt1表达有关。
Abstract:Objective To investigate the effect of the miR-155-5p/silent information regulator 1(sirt1) signaling pathway on the immune function of Candida albicans induced Kawasaki disease model mice. Methods C56BL/6 mice were separated into control group, Kawasaki disease group, antagonist control group, miR-155-5p antagonist group, miR-155-5p antagonist+si-NC group, and miR-155-5p antagonist+si-sirt1 group, with 12 mice in each group. Except for the control group, mice in all other groups were used to construct a Kawasaki disease model by intraperitoneal injection of water-soluble Candida albicans. After successful modeling, administration was performed once a day for 7 days. QRT-PCR was applied to detect the expression of miR-155-5p in coronary arteries. Western blot was applied to detect sirt1 protein in coronary arteries. HE staining was applied to detect pathological changes in coronary arteries. Mouse thymus index and spleen index were detected. Flow cytometry was applied to detect helper T cells 17(Th17)/regulatory T cells(Treg) in peripheral blood. ELISA was applied to detect the levels of interleukin(IL)-17 and IL-10 in mouse serum. The targeting relationship between sirt1 and miR-155-5p was validated. Results Compared with the control group, there was a large amount of inflammatory cell infiltration in the coronary arteries of mice in the Kawasaki disease group. The miR-155-5p expression, Th17 ratio, Th17/Treg ratio, and IL-17 level increased. The sirt1 protein expression, thymus index, spleen index, Treg ratio, and IL-10 level decreased(P<0.05). Compared with the Kawasaki disease group, the inflammatory cell infiltration in the coronary arteries of mice in the miR-155-5p antagonist group was alleviated. The miR-155-5p expression, Th17 ratio, Th17/Treg ratio, and IL-17 level decreased. The sirt1 protein expression, thymus index, spleen index, Treg ratio, and IL-10 level increased(P<0.05). Si-sirt1 weakened the promoting effect of miR-155-5p inhibition on Th17/Treg balance and the inhibitory effect on vascular inflammation in Kawasaki disease mice, miR-155-5p targeted and regulated sirt1. Conclusion The mechanism by which inhibiting miR-155-5p promotes Th17/Treg balance and inhibits vascular inflammation in Kawasaki disease mice may be related to the upregulation of sirt1 expression.
[1] 钱翠平,黄晓碧,赵胜,等.儿童川崎病冠状动脉损伤危险因素Logistic回归分析[J].安徽医科大学学报,2023,58(3):490-4.doi:10.19405/j.cnki.issn1000-1492.2023.03.024.[1] Qian C P,Huang X B,Zhao S,et al.Regression analysis of risk factors related to coronary artery lesion in children with Kawasaki disease[J].Acta Univ Med Anhui,2023,58(3):490-4.doi:10.19405/j.cnki.issn1000-1492.2023.03.024.
[2] Jia C,Zhuge Y,Zhang S,et al.IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway[J].Cell Death Dis,2021,12(6):575.doi:10.1038/s41419-021-03852-z.
[3] Kocatürk B,Lee Y,Nosaka N,et al.Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis[J].JCI Insight,2023,8(14):e169855.doi:10.1172/jci.insight.169855.
[4] Liao Y,Ke B,Long X,et al.Upregulated expression of IL2RB causes disorder of immune microenvironment in patients with Kawasaki disease[J].Biomed Res Int,2022,2022:2114699.doi:10.1155/2022/2114699.
[5] Liu T,Jia J,Wang L,et al.Explore the mechanism of incomplete Kawasaki disease and identify a novel biomarker by weighted gene co-expression network analysis[J].Immunobiology,2022,227(6):152285.doi:10.1016/j.imbio.2022.152285.
[6] 王浩,袁子焰,殷玥,等.白藜芦醇激活Sirt1/Nrf2信号减轻川崎病诱发的心肌损伤[J].心脏杂志,2019,31(6):633-7.doi:10.12125/j.chj.201905037.[6] Wang H,Yuan Z Y,Yin Y,et al.Resveratrol alleviates Kawasaki disease-induced myocardial injury by activating Sirt1/Nrf2 signaling[J].Chin Heart J,2019,31(6):633-7.doi:10.12125/j.chj.201905037.
[7] Wang Y,Zheng Z J,Jia Y J,et al.Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease[J].J Transl Med,2018,16(1):146.doi:10.1186/s12967-018-1486-7.
[8] 郑瑞利,杨慧敏,冯迎军,等.miR-19a-3p靶向上调SOCS3参与急性川崎病病理发展的机制研究[J].中西医结合心脑血管病杂志,2023,21(6):1047-55.doi:10.12102/j.issn.1672-1349.2023.06.013.[8] Zheng R L,Yang H M,Feng Y J,et al.Mechanism of miR-19a-3p targeting up-regulation of SOCS3 and participating in the pathological development of acute Kawasaki disease[J].Chin J Integr Med Cardio Cerebrovasc Dis,2023,21(6):1047-55.doi:10.12102/j.issn.1672-1349.2023.06.013.
[9] Li Y,Zhang H,Li Z,et al.MicroRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis[J].BMC Cardiovasc Disord,2021,21(1):121.doi:10.1186/s12872-020-01742-4.
[10] Su Y,Zhu C,Wang B,et al.Circular RNA FOXO3 in cardiac ischemia-reperfusion injury in heart transplantation:a new regulator and target[J].Am J Transplant,2021,21(9):2992-3004.doi:10.1111/ajt.16475.
[11] 邓康,方梅,贾宁,等.沙冬青种子总黄酮对免疫抑制小鼠的免疫功能及体外脾淋巴细胞增殖的影响[J].中国兽医科学,2018,48(8):1066-72.doi:10.16656/j.issn.1673-4696.2018.0141.[11] Deng K,Fang M,Jia N,et al.Effect of total flavonoids from Ammopiptanthus mongolicus on the immune function in immunosuppressed mice and splenic lymphocyte proliferation in vitro[J].Chin Vet Sci,2018,48(8):1066-72.doi:10.16656/j.issn.1673-4696.2018.0141.
[12] Cavalli G,Colafrancesco S,Emmi G,et al.Interleukin 1α:a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases[J].Autoimmun Rev,2021,20(3):102763.doi:10.1016/j.autrev.2021.102763.
[13] 王璐,顾美珍.阿司匹林和氯吡格雷治疗川崎病的临床效果比较及对患儿凝血功能和免疫功能的影响[J].中国妇幼保健,2023,38(20):3911-5.doi:10.19829/j.zgfybj.issn.1001-4411.2023.20.018.[13] Wang L,Gu M Z.Comparison of clinical effects of aspirin and clopidogrel in the treatment of Kawasaki disease and their effects on coagulation function and immune function of children[J].Matern Child Health Care China,2023,38(20):3911-5.doi:10.19829/j.zgfybj.issn.1001-4411.2023.20.018.
[14] Zheng R,Xie J,Li W,et al.MiR-223-3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3[J].Immun Inflamm Dis,2023,11(7):e939.doi:10.1002/iid3.939.
[15] Cai Y,Hu W.Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis[J].Sci Rep,2022,12(1):21879.doi:10.1038/s41598-022-26608-x.
[16] 李海洲,张琳,王瑾,等.基于SOCS1/STAT3信号通路探讨miR-155对川崎病幼鼠心肌损伤的影响[J].中西医结合心脑血管病杂志,2021,19(12):2004-9.doi:10.12102/j.issn.1672-1349.2021.12.010.[16] Li H Z,Zhang L,Wang J,et al.Effects of miR-155 on myocardial injury in young mice with Kawasaki disease based on SOCS1/STAT3 signaling pathway[J].Chin J Integr Med Cardio Cerebrovasc Dis,2021,19(12):2004-9.doi:10.12102/j.issn.1672-1349.2021.12.010.
[17] Zulkifli N D,Zulkifle N.Insight from sirtuins interactome:topological prominence and multifaceted roles of SIRT1 in modulating immunity,aging and cancer[J].Genomics Inform,2023,21(2):e23.doi:10.5808/gi.23003.
基本信息:
DOI:10.19405/j.cnki.issn1000-1492.2025.02.017
中图分类号:R725.4;R-332
引用信息:
[1]魏刚,田晶,梁冬雪等.miR-155-5p/sirt1信号通路对白色念珠菌诱导川崎病模型小鼠免疫功能的影响[J].安徽医科大学学报,2025,60(02):307-312+320.DOI:10.19405/j.cnki.issn1000-1492.2025.02.017.
基金信息:
辽宁省教育厅基本科研面上项目(编号:LJKMZ20221229)~~